GB879881A - Pharmaceutical preparations containing 6-chloro-7-sulphamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide - Google Patents
Pharmaceutical preparations containing 6-chloro-7-sulphamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxideInfo
- Publication number
- GB879881A GB879881A GB12090/59A GB1209059A GB879881A GB 879881 A GB879881 A GB 879881A GB 12090/59 A GB12090/59 A GB 12090/59A GB 1209059 A GB1209059 A GB 1209059A GB 879881 A GB879881 A GB 879881A
- Authority
- GB
- United Kingdom
- Prior art keywords
- dioxide
- sulphamyl
- benzothiadiazine
- dihydro
- chloro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
A pharmaceutical preparation comprises 6-chloro - 7 - sulphamyl - 3,4 - dihydro - 1,2,4-benzothiadiazine - 1,1 - dioxide (A) or a physiologically tolerable salt thereof and an indole alkaloid of the Apocyanacene family (B) or a physiologically tolerable salt thereof. Salts of (A) are the alkali metal salts such as sodium and potassium mono and polysalts. Salts of (B) are the hydrochloride and sulphate. The preparation may be put up in the form of a tablet, capsule or pill for oral use. The preparations contain 1 to 20, and preferably 2.5 to 10, and particularly 2.5% of (A), and 0.005 to 0.5, and preferably 0.01 to 0.04, and particularly 0.01% of (B). In oral dosage form, the units comprise 10 to 200 mg. and preferably 25 to 100 mg. and particularly 25 mg. of (A) and 0.05 to 5.0 mg. and preferably 0.1 to 0.4 mg. and particularly 0.1 mg. of (B). Specified alkaloids are reserpine, deserpidine and rescinnamine. In one example, (A) and (B) are mixed with silicon dioxide, magnesium stearate and starch, granulated with aqueous starch paste and sufficient 50% aqueous alcohol, and compressed into tablets. Specification 847,064 is referred to.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US879881XA | 1958-04-09 | 1958-04-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB879881A true GB879881A (en) | 1961-10-11 |
Family
ID=22208439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB12090/59A Expired GB879881A (en) | 1958-04-09 | 1959-04-09 | Pharmaceutical preparations containing 6-chloro-7-sulphamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB879881A (en) |
-
1959
- 1959-04-09 GB GB12090/59A patent/GB879881A/en not_active Expired
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB885081A (en) | Improvements in or relating to therapeutic compositions containing (acetylsalicylic acid)-anhydride | |
| HRP20040352A2 (en) | Use of flibanserin in the treatment of sexual disorders | |
| KR100846945B1 (en) | Swallow tablet comprising paracetamol | |
| CA2050970A1 (en) | Pharmaceutical compositions containing furan derivatives | |
| GB879881A (en) | Pharmaceutical preparations containing 6-chloro-7-sulphamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide | |
| US3039922A (en) | Method of administering tablets having decongestant and anti-histaminic activity | |
| GB881377A (en) | Oral-pharmaceutical preparations containing 6-chloro-7-sulphamyl-3:4-dihydro-1:2:4-benzothia-diazine-1:1-dioxide | |
| GB894339A (en) | Pharmaceutical preparations containing 6-chloro-7-sulphamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide | |
| Leyden et al. | Pharmaceutical aspects of reserpine | |
| GB950162A (en) | Medicines for the treatment of hepatic disorders | |
| GB879882A (en) | Pharmaceutical preparations containing 6-chloro-7-sulphamyl-3:4-dihydro-1:2:4-benzothiadiazine-1:1-dioxide | |
| GB947644A (en) | Hypotensive and diuretic compositions comprising alkaloids and a benzothiadiazine-1,1-dioxide derivative | |
| GB1357813A (en) | Effervescent composition for the treatment of heart diseases | |
| ES362231A1 (en) | Dimethylbiguanide Derivative | |
| GB1292496A (en) | Dosage units of contraceptive preparations for human use | |
| GB1202885A (en) | Pharmaceutical compositions comprising alkaloids | |
| GB1098417A (en) | Pharmaceutical compositions having hypotensive activity | |
| GB877464A (en) | Therapeutic anti-depressant compositions comprising hydrazine derivatives | |
| GB1123362A (en) | Diuretic pharmaceutical preparations for oral use | |
| GB908634A (en) | Pharmaceutical compositions containing pararosaniline or derivatives thereof | |
| ES377723A1 (en) | Improvements in pharmaceutical compositions | |
| GB892784A (en) | Pharmaceutical compositions comprising 3-pyridine acetic acid | |
| GB901617A (en) | Oral compositions for promoting skin-pigmentation | |
| GB876320A (en) | Pharmaceutical compositions containing d-3:5-diiodothyronine | |
| ES342394A1 (en) | Novel Benzylaminoimidazoline Derivatives, the preparation thereof and Compositions containing the same |